Computed Tomography

Computed tomography (CT) is a fast and accurate imaging modality often used in emergency settings and trauma imaging. CT scans, with or without (or both) iodinated contrast are frequently used to image the brain, chest, abdomen and pelvis, but also have post-imaging reconstructive capabilities for detailed orthopedic imaging. It is now a standard imaging modality in emergency rooms to quickly assess patients. CT uses a series of X-ray images shot as the gantry rotates around the patient. Computer technology assembles these into into a dataset volume than can be slices on any access, or advanced visualization software can extract specific parts of the anatomy for study. Find more content specific to cardiac CT.

CCTA shows colchicine's impact on atherosclerosis progression
Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.
Tariffs not enough to make Siemens Healthineers move production or raise prices—yet
The imaging manufacturer expects to spend between $227 million and $340 million on tariff mitigation efforts, leaders said Wednesday.
Tariffs will cost Philips Healthcare up to $340M
U.S.-China tariffs will have a $226M to $340M net impact on its bottom line in 2025, even after substantial mitigation efforts, the imaging manufacturer estimates.
AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities
GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Dan Budoff explains use of CCTA to track coronary disease plaque progression

CCTA shows colchicine's impact on atherosclerosis progression

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

Tariffs not enough to make Siemens Healthineers move production or raise prices—yet

The imaging manufacturer expects to spend between $227 million and $340 million on tariff mitigation efforts, leaders said Wednesday.

Tariffs will cost Philips Healthcare up to $340M

U.S.-China tariffs will have a $226M to $340M net impact on its bottom line in 2025, even after substantial mitigation efforts, the imaging manufacturer estimates.

Gudrun Feuchtner, MD, MBA, HCM, assistant professor, cardiovascular imaging, Medical University Innsbruck, Department Radiology, explains how artificial intelligence-based quantitative computed tomography (AI QCT) coronary plaque features are better able to predict risk in women, according the the results of the late-breaking CONFIRM2 study at ACC 2025.

AI-based coronary plaque evaluations highlight elevated heart risks in women

“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.

GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

New scanners and strategies for the ‘golden age of CCTA’

Sponsored by GE Healthcare

As coronary CT angiography (CCTA) continues its rapid expansion, scanner vendors are now offering more economical solutions to ensure access to imaging technology beyond premium systems most often only found at flagship hospitals and academic centers. To conquer CCTA’s technical challenges, new technologies and AI are being incorporated into a new scanner to simplify acquisition and consistently improve image quality.

FDA clears AI-assisted CCTA software that assesses plaques for signs of heart disease

Caristo Diagnostics, an Oxford-based medtech company founded by cardiologists, has gained FDA clearance for its CaRi-Plaque technology.

Building a successful CCTA program: Physicians and healthcare executives to share advice

CCTA continues to grow more and more important in the day-to-day treatment of heart patients. Hospitals and health systems that fail to embrace the modality risk falling behind.

Around the web

Health Imaging

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business

U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.